Study Sample

We have used the adult population from NHANES with individuals who are between [50,80) and Former Smokers as the reference population.

2013 Recommendation

The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.

2020 Recommendation

The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults ages 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.

Simulated Recommendations

2021 Recommendation

The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults ages 55 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.

2022 Recommendation

The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults ages 50 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.

Demographics Table

Prevalence 2020

Proportion of the population that is eligible for lung cancer screening based on the 2013 recommendations and the 2020 recommendation, by select characteristics in respective subpopulations.

Prevalence 2021

Proportion of the population that is eligible for lung cancer screening based on the 2013 recommendations and the 2021 recommendation, by select characteristics in respective subpopulations.

Prevalence 2022

Proportion of the population that is eligible for lung cancer screening based on the 2013 recommendations and the 2022 recommendation, by select characteristics in respective subpopulations.

Factors associated with newly eligible population